Subtopic Deep Dive
Stress Hyperglycemia in Critically Ill Patients
Research Guide
What is Stress Hyperglycemia in Critically Ill Patients?
Stress hyperglycemia in critically ill patients is transient hyperglycemia occurring during acute illness in non-diabetic individuals due to counter-regulatory hormones and insulin resistance.
This condition arises in sepsis, trauma, and ARDS, associating with organ failure and increased mortality. Key trials like NICE-SUGAR (Nice-Sugar Study Investigators, 2009; 5007 citations) showed intensive glucose control (81-108 mg/dL) raised mortality versus conventional (≤180 mg/dL). Van den Berghe et al. (2006; 3630 citations) found intensive insulin reduced morbidity in medical ICU patients staying ≥3 days.
Why It Matters
Stress hyperglycemia predicts poor outcomes in ICU settings, guiding glycemic targets to avoid hypoglycemia risks seen in NICE-SUGAR (Nice-Sugar Study Investigators, 2009). Meta-analysis by Griesdale et al. (2009; 1093 citations) confirmed intensive therapy increases hypoglycemia without mortality benefit except possibly surgical ICU. Finfer (2012; 974 citations) linked moderate/severe hypoglycemia to dose-dependent death risk, informing safer protocols in sepsis and trauma.
Key Research Challenges
Optimal Glycemic Targets
Balancing tight control benefits against hypoglycemia risks remains unresolved post-NICE-SUGAR (Nice-Sugar Study Investigators, 2009). Van den Berghe et al. (2006) showed morbidity reduction in long-stay medical ICU patients but not overall mortality. Meta-analyses like Griesdale et al. (2009) highlight surgical vs. medical ICU differences.
Heterogeneity in Critically Ill
Patient variability in sepsis, trauma, ARDS complicates uniform strategies. NICE-SUGAR (Nice-Sugar Study Investigators, 2009) included diverse ICU adults, finding uniform intensive targets harmful. Umpierrez et al. (2012; 1110 citations) emphasize non-critical care distinctions but stress ICU-specific needs.
Hypoglycemia Risk Prediction
Intensive therapy elevates hypoglycemia independently predicting death (Finfer, 2012; 974 citations). Griesdale et al. (2009) meta-analysis confirmed increased hypoglycemia without survival gain. Identifying at-risk patients pre-emptively challenges current protocols.
Essential Papers
Intensive versus Conventional Glucose Control in Critically Ill Patients
Nice-Sugar Study Investigators · 2009 · New England Journal of Medicine · 5.0K citations
In this large, international, randomized trial, we found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted ...
Intensive Insulin Therapy in the Medical ICU
Greet Van den Berghe, Alexander Wilmer, Greet Hermans et al. · 2006 · New England Journal of Medicine · 3.6K citations
Intensive insulin therapy significantly reduced morbidity but not mortality among all patients in the medical ICU. Although the risk of subsequent death and disease was reduced in patients treated ...
Standards of Medical Care in Diabetes—2010
Unknown · 2009 · Diabetes Care · 3.4K citations
Standards of Medical Care in Diabetes—2009
Unknown · 2008 · Diabetes Care · 2.2K citations
C. Diagnosis of pre-diabetesHyperglycemia not sufficient to meet the diagnostic criteria for diabetes is catego-• •
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Etie S. Moghissi, Mary T. Korytkowski, Monica M. DiNardo et al. · 2009 · Diabetes Care · 1.4K citations
4. Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effecti...
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Elizabeth R. Seaquist, John E. Anderson, Belinda P. Childs et al. · 2013 · Diabetes Care · 1.4K citations
OBJECTIVE To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and...
Standards of Medical Care in Diabetes—2007
Unknown · 2006 · Diabetes Care · 1.2K citations
Cardiovascular disease 1. Hypertension/blood pressure control 2. Dyslipidemia/lipid management 3. Antiplatelet agents 4. Smoking cessation 5. C o r o n a r y h e a r t d i s e a s e screening and t...
Reading Guide
Foundational Papers
Start with NICE-SUGAR (Nice-Sugar Study Investigators, 2009; 5007 citations) for RCT evidence on intensive control mortality increase; follow with Van den Berghe et al. (2006; 3630 citations) for medical ICU insulin therapy morbidity reductions.
Recent Advances
Finfer (2012; 974 citations) on hypoglycemia-death link; Umpierrez et al. (2012; 1110 citations) guideline for hospitalized hyperglycemia management.
Core Methods
RCTs with glucose targets (81-108 vs. ≤180 mg/dL); meta-analyses of mortality/hypoglycemia (Griesdale et al., 2009); observational links to organ failure in stress states.
How PapersFlow Helps You Research Stress Hyperglycemia in Critically Ill Patients
Discover & Search
Research Agent uses citationGraph on NICE-SUGAR (Nice-Sugar Study Investigators, 2009) to map 5007 citing papers, revealing stress hyperglycemia outcome links; exaSearch queries 'stress hyperglycemia sepsis mortality' for 250M+ OpenAlex papers, while findSimilarPapers extends to Van den Berghe et al. (2006).
Analyze & Verify
Analysis Agent applies readPaperContent to extract NICE-SUGAR trial data, then runPythonAnalysis with pandas to compute mortality odds ratios (81-108 vs. ≤180 mg/dL); verifyResponse via CoVe cross-checks claims against Griesdale meta-analysis (2009), with GRADE grading assigning high evidence to ICU target recommendations.
Synthesize & Write
Synthesis Agent detects gaps in post-NICE-SUGAR surgical ICU benefits (Griesdale et al., 2009) and flags contradictions between Van den Berghe (2006) morbidity gains and overall mortality null; Writing Agent uses latexEditText for protocol drafts, latexSyncCitations for 10+ references, and latexCompile for ICU guideline PDFs, with exportMermaid diagramming hormone-insulin resistance pathways.
Use Cases
"Extract survival curves from NICE-SUGAR and plot hazard ratios using Python."
Research Agent → searchPapers 'NICE-SUGAR full text' → Analysis Agent → readPaperContent → runPythonAnalysis (pandas/matplotlib for Kaplan-Meier curves, hazard ratios from raw data) → researcher gets CSV-exported figures with statistical p-values.
"Draft LaTeX review on stress hyperglycemia targets citing NICE-SUGAR and Van den Berghe."
Synthesis Agent → gap detection on glycemic trials → Writing Agent → latexEditText (insert sections) → latexSyncCitations (10 papers) → latexCompile → researcher gets compiled PDF with synced bibliography and figures.
"Find code for ICU glucose simulation models from related papers."
Research Agent → searchPapers 'glucose insulin ICU model' → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Python scripts for stress hyperglycemia simulations with parameter tweaks.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ NICE-SUGAR citing papers via searchPapers → citationGraph → GRADE grading, outputting structured report on stress hyperglycemia mortality. DeepScan applies 7-step analysis with CoVe checkpoints to Van den Berghe (2006) abstracts, verifying morbidity claims against hypoglycemia data (Finfer, 2012). Theorizer generates hypotheses on hormone-driven insulin resistance from ICU trial clusters.
Frequently Asked Questions
What defines stress hyperglycemia in critically ill patients?
Transient hyperglycemia in non-diabetics during acute stress from counter-regulatory hormones and insulin resistance, as contextualized in ICU trials like NICE-SUGAR (Nice-Sugar Study Investigators, 2009).
What methods assess glycemic control in this subtopic?
Randomized trials compare intensive (81-108 mg/dL) vs. conventional (≤180 mg/dL) insulin protocols; meta-analyses aggregate mortality/hypoglycemia risks (Griesdale et al., 2009).
What are key papers on stress hyperglycemia?
NICE-SUGAR (Nice-Sugar Study Investigators, 2009; 5007 citations) showed intensive control harms; Van den Berghe et al. (2006; 3630 citations) found medical ICU morbidity benefits.
What open problems exist?
Optimal targets for heterogeneous ICU populations (sepsis vs. surgical); hypoglycemia prediction independent of glucose control (Finfer, 2012); personalized strategies beyond uniform thresholds.
Research Hyperglycemia and glycemic control in critically ill and hospitalized patients with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Stress Hyperglycemia in Critically Ill Patients with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers